India Glycols delivered impressive fourth-quarter results for the quarter ended March 2026, with consolidated net profit rising 35.71% to ₹86.88 crore compared to ₹64.02 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the company's sales grew 13.11% to ₹976.35 crore during the quarter, up from ₹863.22 crore in Q4 FY25. The strong performance was driven by improved operational efficiency and market conditions.
For the complete financial year ended March 2026, India Glycols demonstrated consistent growth momentum with net profit increasing 26.78% to ₹292.76 crore compared to ₹230.92 crore in the previous year. As reported by Business Standard, the company's annual sales rose 11.76% to ₹4,211.41 crore in FY26, compared to ₹3,768.26 crore in FY25. The full-year performance reflected the company's ability to maintain growth across multiple quarters.
The company's operating profit margin (OPM) improved to 17.05% in Q4 FY26 from 16.91% in the corresponding quarter of the previous year, indicating enhanced operational efficiency. According to the financial data reported by Business Standard, the PBDT (Profit Before Depreciation and Tax) increased 34% to ₹153.69 crore in Q4 FY26 from ₹114.38 crore in Q4 FY25. The PBT (Profit Before Tax) rose 37% to ₹112.46 crore during the quarter, demonstrating strong operational performance across all key metrics.
The robust quarterly and annual results reflect India Glycols' strong operational performance and market positioning. As reported by Business Standard, the company's ability to maintain double-digit growth in sales while achieving significant profit growth indicates effective business strategy execution and favorable market conditions during the reporting period.
